These evidence indicate that dysregulation of the Bmi-1/p16Ink4a pathway likely plays important roles in provoking the aging-associated decline of stem or progenitor cell function and subsequent onset of degenerative diseases. The gene discussed is CDKN2A; the disease is neurodegenerative disease.